Invention Grant
- Patent Title: Efficient cell culture system for hepatitis C virus genotype 6A
-
Application No.: US16961609Application Date: 2019-02-08
-
Publication No.: US12104176B2Publication Date: 2024-10-01
- Inventor: Jens Bukh , Long Van Pham , Santseharay Ramirez Almelda , Judith Margarete Gottwein , Yi-Ping Li , Jannie Pedersen
- Applicant: Hvidovre Hospital
- Applicant Address: DK Hvidovre
- Assignee: Hvidovre Hospital
- Current Assignee: Hvidovre Hospital
- Current Assignee Address: DK Hvidovre
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: DK 1870083 2018.02.09
- International Application: PCT/DK2019/050048 2019.02.08
- International Announcement: WO2019/154472A 2019.08.15
- Date entered country: 2020-07-10
- Main IPC: C12N7/00
- IPC: C12N7/00

Abstract:
The present invention relates to nucleic acid sequences that encode hepatitis C viruses (HCV) of genotype 6a that are useful in the fundamental research of HCV as well as in the search of antivirals and vaccines against HCV. In particular, the present invention relates to nucleic acid sequences that comprises HCVs, which are capable of expressing said virus when transfected into cells and are capable of replication or infectivity in cultured cells.
Public/Granted literature
- US20230250402A1 EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 6A Public/Granted day:2023-08-10
Information query